rs2256774 — IL2RA

IL2RA rs2256774 — A Second Dial on the Treg Thermostat

The IL2RA gene¹¹ IL2RA gene
IL2RA encodes CD25, the alpha chain of the high-affinity IL-2 receptor, essential for regulatory T cell (Treg) development and homeostasis harbors multiple independent regulatory variants that together determine how finely tuned your immune system's self-tolerance machinery is. rs2256774 is an intronic variant in IL2RA that operates in the same regulatory neighbourhood as the better-studied rs2104286²² rs2104286
rs2104286 is the index IL2RA MS/T1D risk variant affecting intron-1 methylation and soluble IL-2RA shedding, but contributes an independent signal. Fine-mapping studies of the IL2RA locus in multiple sclerosis have shown that rs2256774 and rs3118470 together provide the best genotype discrimination for MS risk³³ rs2256774 and rs3118470 together provide the best genotype discrimination for MS risk
Babron et al. demonstrated a combined relative risk of 3.54 between least- and most-at-risk genotype combinations at these two SNPs. The same locus has been identified in a genome-wide association study of psoriasis⁴⁴ genome-wide association study of psoriasis
GWAS Catalog GCST, beta=0.068, p=1×10⁻⁹ for psoriasis susceptibility at rs2256774, extending IL2RA's role across skin-directed and systemic autoimmune diseases.

The Mechanism

IL-2 signaling through the high-affinity receptor complex (CD25/CD122/CD132) is the master maintenance signal for Treg viability and function⁵⁵ master maintenance signal for Treg viability and function
IL-2R stimulation drives pSTAT5, which transcribes FoxP3 and anti-apoptotic genes essential for Treg identity and survival. Intronic variants in IL2RA alter the balance between membrane-anchored CD25 — which captures IL-2 for Treg activation — and soluble IL-2RA (sIL-2RA), a shed ectodomain fragment that acts as a decoy receptor⁶⁶ acts as a decoy receptor
sIL-2RA binds IL-2 with moderate affinity, sequestering it in serum and reducing availability for membrane-bound Treg receptors. When sIL-2RA is elevated, Tregs are present in normal numbers but receive insufficient IL-2 stimulation — a functionally hyporeactive state that impairs suppression of autoreactive T cells.

The IL2RA locus demonstrates allelic heterogeneity⁷⁷ allelic heterogeneity
Different variants at the same locus have distinct effects; one allele may preferentially associate with MS, another with T1D, and a third with both diseases. rs2256774 represents one node in this network: its T allele is associated with increased autoimmune susceptibility, while the C allele is protective. The mechanism parallels rs2104286⁸⁸ mechanism parallels rs2104286
rs2104286 alters allele-specific CpG methylation in intron-1, increasing IL2RA transcription and sIL-2RA shedding, though rs2256774 may act through a distinct regulatory element within the same gene.

The psoriasis connection is mechanistically coherent: psoriasis is a T-cell-driven inflammatory skin condition where Treg/Th17 imbalance⁹⁹ Treg/Th17 imbalance
In psoriatic plaques, reduced Treg suppressive capacity allows Th17 and Th1 effector cells to drive IL-17A and TNF-alpha production is a central driver of keratinocyte hyperproliferation. Impaired Treg function from IL2RA variants creates a permissive environment for psoriatic inflammation.

The Evidence

The most direct evidence for rs2256774's clinical relevance comes from two sources. In MS genetics, Babron et al.¹⁰¹⁰ Babron et al.
Babron MC et al. "Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis." EJHG 2012 analysed 26 IL2RA variants in 522 MS trio families and 244 affected sib-pairs, finding that the two-SNP combination of rs2256774 and rs3118470 outperformed any single variant in discriminating case from control genotype distributions (p-corrected=0.009). The relative risk between least and most at-risk genotype combinations reached 3.54 (95% CI: 2.14–5.94) — a substantially larger effect than the modest single-SNP ORs typically observed at GWAS loci, suggesting that rs2256774 and rs3118470 together tag a haplotype with genuine functional consequence.

The 2007 NEJM MS GWAS¹¹¹¹ 2007 NEJM MS GWAS
International Multiple Sclerosis Genetics Consortium. "Risk alleles for multiple sclerosis identified by a genomewide study." NEJM 2007 identified IL2RA as a genome-wide significant MS risk locus (p=2.96×10⁻⁸) in 12,360 subjects, establishing the locus-level evidence that rs2256774 fine-mapping built upon. The psoriasis association (beta=0.068, p=1×10⁻⁹) represents an independent discovery across a different autoimmune phenotype, corroborating IL2RA's role in skin immune dysregulation.

Functional confirmation comes from Cerosaletti et al.¹²¹² Cerosaletti et al.
Cerosaletti K et al. "Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+CD25hi T cells." PLoS One 2013, who showed that IL2RA risk haplotype carriers demonstrate reduced pSTAT5 in CD4+CD25hi T cells despite normal or increased surface CD25, confirming the sIL-2RA shedding mechanism at the cellular level.

Practical Implications

Because rs2256774 modulates the same IL-2R axis as rs2104286, the actionable interventions overlap: strategies that strengthen Treg function through IL-2-independent pathways are particularly relevant for T-risk-allele carriers.

Vitamin D is a key intervention because 1,25-dihydroxyvitamin D3 drives Treg differentiation through VDR/TGF-beta1 signaling, providing a backup pathway when IL-2 access is limited. Omega-3 fatty acids (EPA in particular) reinforce Treg polarization through PPAR-gamma activation while DHA-derived specialized pro-resolving mediators suppress Th17 differentiation — directly countering the Treg/Th17 imbalance that drives psoriatic inflammation.

For psoriasis-specific monitoring, T-allele carriers should pay attention to skin changes suggestive of psoriasis onset — plaques on elbows, knees, scalp, or the lower back — and to triggers that precipitate flares in genetically susceptible individuals (streptococcal infections, certain medications, stress-induced immune dysregulation).

Interactions

rs2256774 operates within the broader IL2RA regulatory network. [Within the locus | Fine-mapping demonstrates at least three partially independent IL2RA signals in autoimmune disease], it acts in combination with rs3118470 and independently from rs2104286, together determining the magnitude of IL-2 signaling attenuation. Carriers of risk alleles at multiple IL2RA SNPs simultaneously may show additive impairment of Treg function.

Cross-locus interactions with CTLA4 rs3087243 are biologically plausible: CTLA4 delivers co-inhibitory signals that complement Treg suppression, and simultaneous impairment of both IL-2R signaling (rs2256774) and CTLA4 co-inhibition (rs3087243) could produce converging Treg dysfunction. These interactions belong in compound action analysis — individual recommendations here address each variant in isolation.